Blood thinners for hemophilia? one Patient's unprecedented case
NCT ID NCT07314983
First seen Jan 11, 2026 · Last updated Apr 24, 2026 · Updated 16 times
Summary
This study reports on one adult with severe hemophilia A who is receiving long-term anticoagulation (blood thinners). Hemophilia A is a genetic bleeding disorder where blood does not clot properly. The goal is to share how this patient's clotting factor levels and bleeding risks are managed, using newer factor VIII therapies that provide longer protection. The study does not test a new treatment but rather observes and documents a unique medical case.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Laboratoire d'Hématologie - Unité d'Hémostase - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.